{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:06:33Z","timestamp":1790129193611,"version":"4.0.1"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T00:00:00Z","timestamp":1634860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T00:00:00Z","timestamp":1634860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s40618-021-01694-2","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T10:10:33Z","timestamp":1634897433000},"page":"657-673","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["SIGIS\u2013SIAMS\u2013SIE position statement of gender affirming hormonal treatment in transgender and non-binary people"],"prefix":"10.1007","volume":"45","author":[{"given":"A. D.","family":"Fisher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Senofonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Cocchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Guercio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Lingiardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"Meriggiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mosconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ristori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Speranza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pierdominici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Corona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6943-2966","authenticated-orcid":false,"given":"F.","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,22]]},"reference":[{"issue":"2","key":"1694_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.24869\/psyd.2020.145","volume":"32","author":"T Daki\u0107","year":"2020","unstructured":"Daki\u0107 T (2020) New perspectives on transgender health in the forthcoming 11 th revision of the international statistical classification of diseases and related health problems: an overview of gender incongruence - depathologization, considerations and recommendations for practitioners. Psychiatr Danub Summer 32(2):145\u2013150","journal-title":"Psychiatr Danub Summer"},{"issue":"4","key":"1694_CR2","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.jsxm.2020.01.012","volume":"7","author":"G T\u2019Sjoen","year":"2020","unstructured":"T\u2019Sjoen G, Arcelus J, De Vries ALC et al (2020) European Society for sexual medicine position statement \u201cAssessment and Hormonal Management in Adolescent and Adult Trans People, With Attention for Sexual Function and Satisfaction.\u201d J Sex Med 7(4):570\u2013584. https:\/\/doi.org\/10.1016\/j.jsxm.2020.01.012","journal-title":"J Sex Med"},{"issue":"3","key":"1694_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s40618-016-0552-3","volume":"40","author":"AD Fisher","year":"2016","unstructured":"Fisher AD, Castellini G, Ristori J et al (2016) Who has the worst attitudes toward sexual minorities? Comparison of transphobia and homophobia levels in gender dysphoric individuals, the general population and health care providers. J Endocrinol Invest 40(3):263\u2013273. https:\/\/doi.org\/10.1007\/s40618-016-0552-3","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"1694_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/jsm.12363","volume":"11","author":"G Heylens","year":"2014","unstructured":"Heylens G, Verroken C, De Cock S et al (2014) Effects of different steps in gender reassignment therapy on psychopathology: a prospective study of persons with a gender identity disorder. J Sex Med 11(1):119\u2013126. https:\/\/doi.org\/10.1111\/jsm.12363","journal-title":"J Sex Med"},{"key":"1694_CR5","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1210\/jc.2016-1276","volume":"101","author":"AD Fisher","year":"2016","unstructured":"Fisher AD, Castellini G, Ristori J et al (2016) Cross-sex hormone treatment and psychobiological changes in transsexual persons: two-year follow-up data. J Clin Endocrinol Metab 101:4260\u20134269","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1694_CR6","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1743-6109.2011.02564.x","volume":"9","author":"A Gorin-Lazard","year":"2012","unstructured":"Gorin-Lazard A, Baumstarck K, Boyer L et al (2012) Is hormonal therapy associated with better quality of life in transsexuals? A cross-sectional study. J Sex Med 9(2):531\u2013541. https:\/\/doi.org\/10.1111\/j.1743-6109.2011.02564.x","journal-title":"J Sex Med"},{"issue":"3","key":"1694_CR7","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1723\/3245.32146","volume":"5","author":"O Fiorilli","year":"2019","unstructured":"Fiorilli O, Ruocco A (2019) Psychosocial issues in transgender health and barriers to healthcare. Ital J Gender-Specif Med 5(3):123\u2013130. https:\/\/doi.org\/10.1723\/3245.32146","journal-title":"Ital J Gender-Specif Med"},{"key":"1694_CR8","unstructured":"Resolution n. 21756\/ 2019, GU Serie Generale n.52\/2019"},{"key":"1694_CR9","doi-asserted-by":"crossref","unstructured":"Resolutions n. 104272\/2020 and 104273\/2020, GU Serie Generale n.242\/2020","DOI":"10.1016\/j.livsci.2020.104272"},{"issue":"6","key":"1694_CR10","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jadohealth.2019.12.018","volume":"66","author":"AIR van der Miesen","year":"2020","unstructured":"van der Miesen AIR, Steensma TD, de Vries ALC et al (2020) Psychological functioning in transgender adolescents before and after gender-affirmative care compared with cisgender general population peers. J Adolesc Health 66(6):699\u2013704. https:\/\/doi.org\/10.1016\/j.jadohealth.2019.12.018","journal-title":"J Adolesc Health"},{"issue":"9","key":"1694_CR11","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1037\/a0039906","volume":"70","author":"American Psychological Association","year":"2015","unstructured":"American Psychological Association (2015) Guidelines for psychological practice with transgender and gender nonconforming people. Am Psychol 70(9):832\u2013864. https:\/\/doi.org\/10.1037\/a0039906","journal-title":"Am Psychol"},{"issue":"3","key":"1694_CR12","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1210\/jc.2007-1907","volume":"93","author":"BA Swiglo","year":"2008","unstructured":"Swiglo BA, Murad MH, Schunemann HJ et al (2008) A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. J Clin Endocrinol Metab 93(3):666\u2013673. https:\/\/doi.org\/10.1210\/jc.2007-1907","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1694_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/pcn.12947","volume":"74","author":"LD de Freitas","year":"2020","unstructured":"de Freitas LD, L\u00e9da-R\u00eago G, Bezerra-Filho S et al (2020) Psychiatric disorders in individuals diagnosed with gender dysphoria: a systematic review. Psychiatry Clin Neurosci 74(2):99\u2013104. https:\/\/doi.org\/10.1111\/pcn.12947","journal-title":"Psychiatry Clin Neurosci"},{"issue":"1","key":"1694_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3109\/09540261.2015.1115753","volume":"28","author":"C Dhejne","year":"2016","unstructured":"Dhejne C, Van Vlerken R, Heylens G et al (2016) Mental health and gender dysphoria: a review of the literature. Int Rev Psychiatry 28(1):44\u201357. https:\/\/doi.org\/10.3109\/09540261.2015.1115753","journal-title":"Int Rev Psychiatry"},{"issue":"3","key":"1694_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1300\/J082v51n03_04","volume":"51","author":"K Clements-Nolle","year":"2006","unstructured":"Clements-Nolle K, Marx R, Katz M (2006) Attempted suicide among transgender persons: the influence of gender-based discrimination and victimization. J Homosex 51(3):53\u201369. https:\/\/doi.org\/10.1300\/J082v51n03_04","journal-title":"J Homosex"},{"key":"1694_CR16","doi-asserted-by":"publisher","first-page":"66e74","DOI":"10.1080\/15532739.2013.791650","volume":"14","author":"GR Bauer","year":"2013","unstructured":"Bauer GR, Redman N, Bradley K et al (2013) Sexual health of trans men who are gay, bisexual, or who have sex with men: results from Ontario, Canada. Int J Transgend 14:66e74. https:\/\/doi.org\/10.1080\/15532739.2013.791650","journal-title":"Int J Transgend"},{"key":"1694_CR17","first-page":"601","volume-title":"Adult psychopathology and diagnosis","author":"A Lawrence","year":"2012","unstructured":"Lawrence A, Zucker K (2012) Gender identity disorders. In: Hersen M, Beidel D (eds) Adult psychopathology and diagnosis, 6th edn. Wiley, London, pp 601\u2013635","edition":"6"},{"issue":"3","key":"1694_CR18","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s10508-007-9307-8","volume":"38","author":"E G\u00f3mez-Gil","year":"2009","unstructured":"G\u00f3mez-Gil E, Trilla A, Salamero M et al (2009) Sociodemographic, clinical, and psychiatric characteristics of transsexuals from Spain. Arch Sex Behav 38(3):378\u2013392. https:\/\/doi.org\/10.1007\/s10508-007-9307-8","journal-title":"Arch Sex Behav"},{"issue":"2","key":"1694_CR19","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/j.1743-6109.2012.03006.x","volume":"10","author":"AD Fisher","year":"2013","unstructured":"Fisher AD, Bandini E, Casale H et al (2013) Sociodemographic and clinical features of gender identity disorder: an Italian multicentric evaluation. J Sex Med 10(2):408\u2013419. https:\/\/doi.org\/10.1111\/j.1743-6109.2012.03006.x","journal-title":"J Sex Med"},{"issue":"2","key":"1694_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1192\/bjp.bp.112.121954","volume":"204","author":"G Heylens","year":"2014","unstructured":"Heylens G, Elaut E, Kreukels BP et al (2014) Psychiatric characteristics in transsexual individuals: multicentre study in four European countries. Br J Psychiatry J Mental Sci 204(2):151\u2013156. https:\/\/doi.org\/10.1192\/bjp.bp.112.121954","journal-title":"Br J Psychiatry J Mental Sci"},{"key":"1694_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12413","author":"AD Fisher","year":"2014","unstructured":"Fisher AD, Castellini G, Bandini E et al (2014) Cross-sex hormonal treatment and body uneasiness in individuals with gender dysphoria. Sex Med. https:\/\/doi.org\/10.1111\/jsm.12413","journal-title":"Sex Med"},{"issue":"4","key":"1694_CR22","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1111\/jsm.12062","volume":"10","author":"E Bandini","year":"2013","unstructured":"Bandini E, Fisher AD, Castellini G et al (2013) Gender identity disorder and eating disorders: similarities and differences in terms of body uneasiness. J Sex Med 10(4):1012\u20131023. https:\/\/doi.org\/10.1111\/jsm.12062","journal-title":"J Sex Med"},{"issue":"11","key":"1694_CR23","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1097\/NMD.0000000000000046","volume":"201","author":"A Gorin-Lazard","year":"2013","unstructured":"Gorin-Lazard A, Baumstarck K, Boyer L, Maquigneau A et al (2013) Hormonal therapy is associated with better self-esteem, mood, and quality of life in transsexuals. J Nerv Ment Dis 201(11):996\u20131000. https:\/\/doi.org\/10.1097\/NMD.0000000000000046","journal-title":"J Nerv Ment Dis"},{"issue":"1","key":"1694_CR24","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12888-017-1423-y","volume":"17","author":"H Oda","year":"2017","unstructured":"Oda H, Kinoshita T (2017) Efficacy of hormonal and mental treatments with MMPI in FtM individuals: cross-sectional and longitudinal studies. BMC Psychiatry 17(1):256. https:\/\/doi.org\/10.1186\/s12888-017-1423-y","journal-title":"BMC Psychiatry"},{"issue":"11","key":"1694_CR25","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1210\/jc.2016-1276","volume":"101","author":"AD Fisher","year":"2016","unstructured":"Fisher AD, Castellini G, Ristori J et al (2016) Cross-sex hormone treatment and psychobiological changes in transsexual persons: two-year follow-up data. J Clin Endocrinol Metab 101(11):4260\u20134269. https:\/\/doi.org\/10.1210\/jc.2016-1276","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1694_CR26","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1002\/lary.26716","volume":"127","author":"C Bultynck","year":"2017","unstructured":"Bultynck C, Pas C, Defreyne J et al (2017) 2804Self-perception of voice in transgender persons during cross-sex hormone therapy. Laryngoscope 127(12):2796\u20132804. https:\/\/doi.org\/10.1002\/lary.26716","journal-title":"Laryngoscope"},{"issue":"6","key":"1694_CR27","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.3390\/ijms21062123","volume":"21","author":"J Ristori","year":"2020","unstructured":"Ristori J, Cocchetti C, Romani A et al (2020) Brain sex differences related to gender identity development: genes or hormones? Int J Mol Sci 21(6):2123. https:\/\/doi.org\/10.3390\/ijms21062123","journal-title":"Int J Mol Sci"},{"key":"1694_CR28","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.2147\/NDT.S95310","volume":"12","author":"R Costa","year":"2016","unstructured":"Costa R, Colizzi M (2016) The effect of cross-sex hormonal treatment on gender dysphoria individuals\u2019 mental health: a systematic review. Neuropsychiatr Dis Treat 12:1953\u20131966. https:\/\/doi.org\/10.2147\/NDT.S95310","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"12","key":"1694_CR29","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s11920-018-0973-0","volume":"20","author":"HB Nguyen","year":"2018","unstructured":"Nguyen HB, Chavez AM, Lipner E et al (2018) Gender-affirming hormone use in transgender individuals: impact on behavioral health and cognition. Curr Psychiatry Rep 20(12):110. https:\/\/doi.org\/10.1007\/s11920-018-0973-0","journal-title":"Curr Psychiatry Rep"},{"issue":"10042","key":"1694_CR30","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0140-6736(16)00682-6","volume":"388","author":"K Wylie","year":"2016","unstructured":"Wylie K, Knudson G, Khan SI et al (2016) Serving transgender people: clinical care considerations and service delivery models in transgender health. Lancet 388(10042):401\u2013411. https:\/\/doi.org\/10.1016\/S0140-6736(16)00682-6","journal-title":"Lancet"},{"issue":"3","key":"1694_CR31","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1037\/pst0000034","volume":"52","author":"SL Budge","year":"2015","unstructured":"Budge SL (2015) Psychotherapists as gatekeepers: an evidence-based case study highlighting the role and process of letter writing for transgender clients. Psychotherapy 52(3):287","journal-title":"Psychotherapy"},{"issue":"3\u20134","key":"1694_CR32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1300\/J485v09n03_03","volume":"9","author":"WO Bockting","year":"2006","unstructured":"Bockting WO, Knudson G, Goldberg JM (2006) Counseling and mental health care for transgender adults and loved ones. Int J Transgenderism 9(3\u20134):35\u201382. https:\/\/doi.org\/10.1300\/J485v09n03_03","journal-title":"Int J Transgenderism"},{"issue":"4","key":"1694_CR33","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/15532739.2011.700873","volume":"13","author":"E Coleman","year":"2012","unstructured":"Coleman E, Bockting W, Botzer M et al (2012) Standards of care for the health of transsexual, transgender, and gender-nonconforming people, Version 7. Int J Transgenderism 13(4):165\u2013232. https:\/\/doi.org\/10.1080\/15532739.2011.700873","journal-title":"Int J Transgenderism"},{"issue":"5","key":"1694_CR34","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.jsxm.2018.03.079","volume":"15","author":"J Defreyne","year":"2018","unstructured":"Defreyne J, T\u2019Sjoen G, Bouman WP et al (2018) Prospective evaluation of self-reported aggression in transgender persons. J Sex Med 15(5):768\u2013776. https:\/\/doi.org\/10.1016\/j.jsxm.2018.03.079","journal-title":"J Sex Med"},{"issue":"3","key":"1694_CR35","doi-asserted-by":"publisher","first-page":"264","DOI":"10.17744\/mehc.31.3.f62415468l133w50","volume":"31","author":"G Bess","year":"2009","unstructured":"Bess G, Stabb S (2009) The experiences of transgendered persons in psychotherapy: voices and recommendations. J Mental Health Counsel 31(3):264\u2013282. https:\/\/doi.org\/10.17744\/mehc.31.3.f62415468l133w50","journal-title":"J Mental Health Counsel"},{"key":"1694_CR36","unstructured":"Rachlin K (2002) Transgender Individual's Experiences of Psychotherapy, Paper presented at the American Psychological Association 109thAnnual Convention, San Francisco, CA"},{"issue":"2","key":"1694_CR37","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.ecl.2019.01.004","volume":"48","author":"J Defreyne","year":"2019","unstructured":"Defreyne J, T\u2019Sjoen G (2019) Transmasculine hormone therapy. Endocrinol Metab Clin North Am 48(2):357\u2013375. https:\/\/doi.org\/10.1016\/j.ecl.2019.01.004","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"11","key":"1694_CR38","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1210\/jc.2017-01658","volume":"102","author":"WC Hembree","year":"2017","unstructured":"Hembree WC, Cohen-Kettenis PT, Gooren L et al (2017) Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an endocrine society* clinical practice guideline. J Clin Endocrinol Metab 102(11):3869\u20133903","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1694_CR39","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1111\/jsm.12698","volume":"11","author":"C Pelusi","year":"2014","unstructured":"Pelusi C, Costantino A, Martelli V et al (2014) Effects of three different testosterone formulations in female-to-male transsexual persons. J Sex Med 11(12):3002\u20133011. https:\/\/doi.org\/10.1111\/jsm.12698","journal-title":"J Sex Med"},{"issue":"3","key":"1694_CR40","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/andr.12485","volume":"6","author":"J Defreyne","year":"2018","unstructured":"Defreyne J, Vantomme B, Van Caenegem E et al (2018) Prospective evaluation of hematocrit in gender-affirming hormone treatment: results from European Network for the Investigation of Gender Incongruence. Andrology 6(3):446\u2013454. https:\/\/doi.org\/10.1111\/andr.12485","journal-title":"Andrology"},{"issue":"6","key":"1694_CR41","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/cen.13821","volume":"89","author":"G Gava","year":"2018","unstructured":"Gava G, Mancini I, Cerpolini S et al (2018) Testosterone undecanoate and testosterone enanthate injections are both effective and safe in transmen over 5 years of administration. Clin Endocrinol (Oxf) 89(6):878\u2013886","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"1694_CR42","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/26895269.2020.1719951","volume":"21","author":"J Defreyne","year":"2020","unstructured":"Defreyne J, Vanwonterghem Y, Collet S et al (2020) Vaginal bleeding and spotting in transgender men after initiation of testosterone therapy: a prospective cohort study (ENIGI). Int J Transgend Health 21(2):163\u2013175. https:\/\/doi.org\/10.1080\/26895269.2020.1719951","journal-title":"Int J Transgend Health"},{"issue":"10","key":"1694_CR43","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1111\/j.1743-6109.2008.00909.x","volume":"5","author":"MC Meriggiola","year":"2008","unstructured":"Meriggiola MC, Armillotta F, Costantino A et al (2008) Effects of testosterone undecanoate administered alone or in combination with letrozole or dutasteride in female to male transsexuals. J Sex Med 5(10):2442\u20132453","journal-title":"J Sex Med"},{"issue":"1","key":"1694_CR44","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/andr.12278","volume":"5","author":"MS Irwig","year":"2016","unstructured":"Irwig MS, Childs K, Hancock AB (2016) Effects of testosterone on the transgender male voice. Andrology 5(1):107\u2013112. https:\/\/doi.org\/10.1111\/andr.12278","journal-title":"Andrology"},{"issue":"1","key":"1694_CR45","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/jsm.12366","volume":"11","author":"K Wierckx","year":"2014","unstructured":"Wierckx K, Van de Peer F, Verhaeghe E et al (2014) Short- and long-term clinical skin effects of testosterone treatment in trans men. J Sex Med gennaio 11(1):222\u2013229. https:\/\/doi.org\/10.1111\/jsm.12366","journal-title":"J Sex Med gennaio"},{"issue":"1","key":"1694_CR46","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jsxm.2019.10.008","volume":"17","author":"J Ristori","year":"2020","unstructured":"Ristori J, Cocchetti C, Castellini G et al (2020) Hormonal treatment effect on sexual distress in transgender persons: 2-year follow-up data. J Sex Med 17(1):142\u2013151. https:\/\/doi.org\/10.1016\/j.jsxm.2019.10.008","journal-title":"J Sex Med"},{"issue":"8","key":"1694_CR47","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.jsxm.2019.05.009","volume":"16","author":"D van Dijk","year":"2019","unstructured":"van Dijk D, Dekker MJHJ, Conemans EB et al (2019) Explorative prospective evaluation of short-term subjective effects of hormonal treatment in trans people-results from the european network for the investigation of gender incongruence. J Sex Med 16(8):1297\u20131309. https:\/\/doi.org\/10.1016\/j.jsxm.2019.05.009","journal-title":"J Sex Med"},{"issue":"4","key":"1694_CR48","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1530\/EJE-10-1038","volume":"164","author":"H Asscheman","year":"2011","unstructured":"Asscheman H, Giltay EJ, Megens JAJ et al (2011) A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones. Eur J Endocrinol 164(4):635\u2013642","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"1694_CR49","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/and.12150","volume":"46","author":"H Asscheman","year":"2014","unstructured":"Asscheman H, T\u2019Sjoen G, Lemaire A et al (2014) Venous thromboembolism as a complication of cross-sex hormone treatment of male-to-female transsexual subjects: a review. Andrologia 46(7):791\u2013795. https:\/\/doi.org\/10.1111\/and.12150","journal-title":"Andrologia"},{"issue":"2","key":"1694_CR50","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ecl.2019.02.001","volume":"48","author":"O Hamidi","year":"2019","unstructured":"Hamidi O, Davidge-Pitts CJ (2019) Transfeminine hormone therapy. Endocrinol Metab Clin North Am 48(2):341\u2013355. https:\/\/doi.org\/10.1016\/j.ecl.2019.02.001","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"6","key":"1694_CR51","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.jsxm.2016.03.371","volume":"13","author":"HJ Dekker","year":"2016","unstructured":"Dekker HJ, Wierckx K, Van Caenegem E et al (2016) A european network for the investigation of gender incongruence: endocrine part. J Sex Med 13(6):994\u2013999. https:\/\/doi.org\/10.1016\/j.jsxm.2016.03.371","journal-title":"J Sex Med"},{"issue":"5\u20136","key":"1694_CR52","doi-asserted-by":"publisher","first-page":"E458","DOI":"10.5489\/cuaj.1753","volume":"8","author":"JH Kim","year":"2014","unstructured":"Kim JH, Yoo BW, Yang WJ (2014) Hepatic failure induced by cyproterone acetate: a case report and literature review. Can Urol Assoc J 8(5\u20136):E458\u2013E461. https:\/\/doi.org\/10.5489\/cuaj.1753","journal-title":"Can Urol Assoc J"},{"issue":"1","key":"1694_CR53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/15532739.2016.1258353","volume":"18","author":"N Millet","year":"2016","unstructured":"Millet N, Longworth J, Arcelus J (2016) Prevalence of anxiety symptoms and disorders in the transgender population: a systematic review of the literature. Int J Transgenderism 18(1):27\u201338","journal-title":"Int J Transgenderism"},{"issue":"5","key":"1694_CR54","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1089\/lgbt.2016.0190","volume":"4","author":"J Defreyne","year":"2017","unstructured":"Defreyne J, Nota N, Pereira C et al (2017) Transient elevated serum prolactin in trans women is caused by cyproterone acetate treatment. LGBT Health 4(5):328\u2013333","journal-title":"LGBT Health"},{"issue":"6","key":"1694_CR55","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1080\/09513590.2017.1395839","volume":"34","author":"I Mancini","year":"2018","unstructured":"Mancini I, Rotilio A, Coati I et al (2018) Presentation of a meningioma intranswoman after nine years of cyproterone acetate and estradiol intake: case report and literature review. Gynecol Endocrinol 34(6):456\u2013459. https:\/\/doi.org\/10.1080\/09513590.2017.1395839","journal-title":"Gynecol Endocrinol"},{"key":"1694_CR56","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1111\/and.12550","volume":"48","author":"PV Ter Wengel","year":"2016","unstructured":"Ter Wengel PV, Martin E, Gooren L et al (2016) (2016) Meningiomas in three male-to-female transgender subjects using oestrogens\/progestogens and review of the literature. Andrologia 48:1130\u20131137. https:\/\/doi.org\/10.1111\/and.12550","journal-title":"Andrologia"},{"key":"1694_CR57","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/cen.13050","volume":"85","author":"G Gava","year":"2016","unstructured":"Gava G, Cerpolini S, Martelli V et al (2016) Cyproterone acetate vs leuprolide acetate in combination with transdermal oestradiol in transwomen: a comparison of safety and effectiveness. Clin Endocrinol (Oxf) 85:239\u2013246. https:\/\/doi.org\/10.1111\/cen.13050","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"1694_CR58","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1055\/s-2005-865900","volume":"113","author":"R Dittrich","year":"2005","unstructured":"Dittrich R, Binder H, Cupisti S et al (2005) Endocrine treatment of maleto-female transsexuals using gonadotropin-releasing hormone agonist. Exp Clin Endocrinol Diabetes 113(10):586\u2013592","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"6","key":"1694_CR59","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1530\/EJE-20-0370","volume":"183","author":"G Gava","year":"2020","unstructured":"Gava G, Mancini I, Alvisi S et al (2020) A comparison of 5-year administration of cyproterone acetate or leuprolide acetate in combination with estradiol in transwomen. Eur J Endocrinol 183(6):561\u2013569. https:\/\/doi.org\/10.1530\/EJE-20-0370","journal-title":"Eur J Endocrinol"},{"key":"1694_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cen.14329Jun2020","volume":"00","author":"LM Angus","year":"2020","unstructured":"Angus LM, Nolan BJ, Zajac JD et al (2020) A systematic review of antiandrogens and feminization in transgender women. Clin Endocrinol 00:1\u201310. https:\/\/doi.org\/10.1111\/cen.14329Jun2020","journal-title":"Clin Endocrinol"},{"issue":"1","key":"1694_CR61","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1089\/trgh.2016.0022","volume":"1","author":"MO Stevenson","year":"2016","unstructured":"Stevenson MO, Wixon N, Safer JD (2016) Scalp hair regrowth in hormone-treated transgender woman. Transgend Health 1(1):202\u2013204","journal-title":"Transgend Health"},{"key":"1694_CR62","doi-asserted-by":"publisher","DOI":"10.1111\/andr.12881","author":"MS Irwig","year":"2020","unstructured":"Irwig MS (2020) Is there a role for 5alpha-reductase inhibitors in transgender individuals? Andrology. https:\/\/doi.org\/10.1111\/andr.12881 (Online ahead of print)","journal-title":"Andrology"},{"issue":"4","key":"1694_CR63","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1210\/jc.2018-01777","volume":"104","author":"JC Prior","year":"2019","unstructured":"Prior JC (2019) Progesterone is important for transgender women\u2019s therapy\u2014applying evidence for the benefits of progesterone in ciswomen. J Clin Endocrinol Metab 104(4):1181\u20131186","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1694_CR64","doi-asserted-by":"publisher","first-page":"5148","DOI":"10.1210\/jc.2018-02253","volume":"104","author":"J Jain","year":"2019","unstructured":"Jain J, Kwan D, Forcier M (2019) Medroxyprogesterone acetate in gender-affirming therapy for transwomen: results from a retrospective study. J Clin Endocrinol Metab 104(11):5148\u20135156","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1694_CR65","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1210\/er.2018-00011","volume":"40","author":"G T\u2019Sjoen","year":"2019","unstructured":"T\u2019Sjoen G, Arcelus J, Gooren L et al (2019) Endocrinology of Transgender Medicine. Endocr Rev 40(1):97\u2013117. https:\/\/doi.org\/10.1210\/er.2018-00011","journal-title":"Endocr Rev"},{"issue":"2","key":"1694_CR66","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jsxm.2019.10.021","volume":"17","author":"CJM de Blok","year":"2019","unstructured":"de Blok CJM, Staphorsius AS, Wiepjes CM et al (2019) Frequency, determinants, and satisfaction of breast augmentation in trans women receiving hormone treatment. J Sex Med 17(2):342\u2013348. https:\/\/doi.org\/10.1016\/j.jsxm.2019.10.021","journal-title":"J Sex Med"},{"key":"1694_CR67","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1210\/jcem.85.4.6562","volume":"85","author":"EJ Giltay","year":"2000","unstructured":"Giltay EJ, Fonk JC, von Blomberg BM et al (2000) In vivo effects of sex steroids on lymphocyte respon-siveness and immunoglobulin levels in humans. J Clin EndocrinolMetab 85:1648\u20131657. https:\/\/doi.org\/10.1210\/jcem.85.4.6562","journal-title":"J Clin EndocrinolMetab"},{"issue":"2","key":"1694_CR68","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1530\/EJE-17-0496","volume":"178","author":"M Klaver","year":"2018","unstructured":"Klaver M, de Blok CJM, Wiepjes CM et al (2018) Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study. Eur J Endocrinol 178(2):163\u2013171. https:\/\/doi.org\/10.1530\/EJE-17-0496","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"1694_CR69","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1002\/lary.26716","volume":"127","author":"C Bultynck","year":"2017","unstructured":"Bultynck C, Pas C, Defreyne J et al (2017) Self-perception of voice in transgender persons during cross-sex hormone therapy. Laryngoscope 127(12):2796\u20132804. https:\/\/doi.org\/10.1002\/lary.26716","journal-title":"Laryngoscope"},{"issue":"2","key":"1694_CR70","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/BF01542220","volume":"15","author":"WJ Meyer III","year":"1986","unstructured":"Meyer WJ III, Webb A, Stuart CA et al (1986) Physical and hormonal evaluation of transsexual patients: a longitudinal study. Arch Sex Behav 15(2):121\u2013138. https:\/\/doi.org\/10.1007\/BF01542220","journal-title":"Arch Sex Behav"},{"issue":"4","key":"1694_CR71","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.jsxm.2019.12.020","volume":"17","author":"J Defreyne","year":"2020","unstructured":"Defreyne J, Elaut E, Kreukels B et al (2020) Sexual desire changes in transgender individuals upon initiation of hormone treatment: results from the Investigation of gender incongruence. J Sex Med 17(4):812\u2013825. https:\/\/doi.org\/10.1016\/j.jsxm.2019.12.020","journal-title":"J Sex Med"},{"issue":"6","key":"1694_CR72","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.3390\/jcm9061609","volume":"9","author":"C Cocchetti","year":"2020","unstructured":"Cocchetti C, Ristori J, Romani A (2020) Hormonal treatment strategies tailored to non-binary transgender individuals. J Clin Med 9(6):1609. https:\/\/doi.org\/10.3390\/jcm9061609","journal-title":"J Clin Med"},{"key":"1694_CR73","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S2213-8587(18)30047-0","volume":"6","author":"TD Rachner","year":"2018","unstructured":"Rachner TD, Coleman R, Hadji P et al (2018) Bone health during endocrine therapy for cancer. Lancet Diabetes Endocrinol 6:901\u2013910. https:\/\/doi.org\/10.1016\/S2213-8587(18)30047-0","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1694_CR74","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1210\/jc.2018-00241","volume":"103","author":"KA Martin","year":"2018","unstructured":"Martin KA, Anderson RR, Chang RJ et al (2018) Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 103:1233\u20131257. https:\/\/doi.org\/10.1210\/jc.2018-00241","journal-title":"J Clin Endocrinol Metab"},{"key":"1694_CR75","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/BF03345676","volume":"32","author":"K Unluhizarci","year":"2009","unstructured":"Unluhizarci K, Ozel D, Tanriverdi F et al (2009) A comparison between finasteride, flutamide, and finasteride plus flutamide combination in the treatment of hirsutism. J Endocrinol Invest 32:37\u201340. https:\/\/doi.org\/10.1007\/BF03345676","journal-title":"J Endocrinol Invest"},{"key":"1694_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2020.12.015","author":"G Gava","year":"2021","unstructured":"Gava G, Armillotta F, Pillastrini P et al (2021) A randomized double-blind placebo-controlled pilot trial on the effects of testosterone undecanoate plus dutasteride or placebo on muscle strength, body composition, and metabolic profile in transmen. J Sex Med. https:\/\/doi.org\/10.1016\/j.jsxm.2020.12.015","journal-title":"J Sex Med"},{"key":"1694_CR77","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/1346-8138.13312","volume":"43","author":"S Ingprasert","year":"2016","unstructured":"Ingprasert S, Tanglertsampa C, Tangphianphan N (2016) Efficacy and safety of minoxidil 3% lotion for beard enhancement: a randomized, double-masked, placebo-controlled study. J Dermatol 43:968\u2013969. https:\/\/doi.org\/10.1111\/1346-8138.13312","journal-title":"J Dermatol"},{"key":"1694_CR78","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1097\/01.AOG.0000292083.97478.38","volume":"110","author":"K Dickersin","year":"2007","unstructured":"Dickersin K, Munro MG, Clark M (2007) Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding: a randomized controlled trial. OBSTET Gynecol 110:1279\u20131289. https:\/\/doi.org\/10.1097\/01.AOG.0000292083.97478.38","journal-title":"OBSTET Gynecol"},{"key":"1694_CR79","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40695-018-0042-1","volume":"4","author":"A Francis","year":"2018","unstructured":"Francis A, Jasani S, Bachmann G (2018) Contraceptive challenges and the transgender individual. Womens Midlife Health 4:12","journal-title":"Womens Midlife Health"},{"issue":"1","key":"1694_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2265.2009.03632.x","volume":"72","author":"MB Elamin","year":"2010","unstructured":"Elamin MB, Garcia MZ, Murad MH et al (2010) (2010) Effect of sex steroid use on cardiovascular risk in transsexual individuals: a systematic review and meta-analyses. Clin Endocrinol (Oxf) 72(1):1\u201310. https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03632.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"1694_CR81","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/j.1745-7262.2006.00204.x","volume":"8","author":"M Berra","year":"2006","unstructured":"Berra M, Armillotta L, D\u2019Emidio F et al (2006) Testosterone decreases adiponectin levels in female to male transsexuals. Asian J Androl 8(6):725\u2013729. https:\/\/doi.org\/10.1111\/j.1745-7262.2006.00204.x","journal-title":"Asian J Androl"},{"issue":"6","key":"1694_CR82","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1210\/jc.2018-02138","volume":"104","author":"DM Van Velzen","year":"2019","unstructured":"Van Velzen DM, Al P, Klaver M et al (2019) Cardiometabolic effects of testosterone in transmen and estrogen plus cyproterone acetate in transwomen. J Clin Endocrinol Metab 104(6):1937\u20131947. https:\/\/doi.org\/10.1210\/jc.2018-02138","journal-title":"J Clin Endocrinol Metab"},{"key":"1694_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsxm.2021.01.185","author":"C Cocchetti","year":"2021","unstructured":"Cocchetti C, Castellini G, Iacuaniello D et al (2021) Does gender-affirming hormonal treatment affect 30-year cardiovascular risk in transgender persons? A two-year prospective European study (ENIGI). J Sex Med. https:\/\/doi.org\/10.1016\/j.jsxm.2021.01.185","journal-title":"J Sex Med"},{"key":"1694_CR84","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1210\/jc.2017-01643","volume":"102","author":"S Maraka","year":"2017","unstructured":"Maraka S, Singh Ospina N, Rodriguez-Gutierrez R et al (2017) Sex steroids and cardiovascular outcomes in transgender individuals: a systematic review and meta-analysis. J Clin Endocrinol Metab 102:3914\u20133923. https:\/\/doi.org\/10.1210\/jc.2017-01643","journal-title":"J Clin Endocrinol Metab"},{"key":"1694_CR85","doi-asserted-by":"publisher","first-page":"205","DOI":"10.7326\/M17-2785","volume":"169","author":"D Getahun","year":"2018","unstructured":"Getahun D, Nash R, Flanders WD et al (2018) Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study. Ann Intern Med 169:205\u2013213. https:\/\/doi.org\/10.7326\/M17-2785","journal-title":"Ann Intern Med"},{"key":"1694_CR86","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/andr.12485","volume":"6","author":"J Defreyne","year":"2018","unstructured":"Defreyne J, Vantomme B, Van Caenegem E et al (2018) Prospective evaluation of hematocrit in gender-affirming hormone treatment: results from European network for the investigation of gender incongruence. Andrology 6:446\u2013454. https:\/\/doi.org\/10.1111\/andr.12485","journal-title":"Andrology"},{"issue":"2","key":"1694_CR87","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1530\/EJE-14-0586","volume":"172","author":"E Van Caenegem","year":"2015","unstructured":"Van Caenegem E, Wierckx K, Taes Y et al (2015) 2015) Body composition, bone turnover, and bone mass in trans men during testosterone treatment: 1-year follow-up data from a prospective casecontrolled study (ENIGI. Eur J Endocrinol 172(2):163\u2013171. https:\/\/doi.org\/10.1530\/EJE-14-0586","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"1694_CR88","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/j.1365-2265.2004.02125.x","volume":"61","author":"A Turner","year":"2004","unstructured":"Turner A, Chen TC, Barber TW et al (2004) Testosterone increases bone mineral density in female-to-male transsexuals: a case series of 15 subjects. Clin Endocrinol (Oxf) 61(5):560\u2013566. https:\/\/doi.org\/10.1111\/j.1365-2265.2004.02125.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"1694_CR89","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1046\/j.1365-2265.1998.00396.x","volume":"48","author":"P van Kesteren","year":"1998","unstructured":"van Kesteren P, Lips P, Gooren LJG et al (1998) Long-term follow-up of bone mineral density and bone metabolism in transsexuals treated with cross-sex hormones. Clin Endocrinol (Oxf) 48(3):347\u2013354. https:\/\/doi.org\/10.1046\/j.1365-2265.1998.00396.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"1694_CR90","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1046\/j.1365-2265.2003.01753.x","volume":"58","author":"JMH Elbers","year":"2003","unstructured":"Elbers JMH, Giltay EJ, Teerlink T et al (2003) Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects. Clin Endocrinol (Oxf) 58(5):562\u2013571. https:\/\/doi.org\/10.1046\/j.1365-2265.2003.01753.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"1694_CR91","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.1365-2265.2009.03625.x","volume":"72","author":"MH Murad","year":"2010","unstructured":"Murad MH, Elamin MB, Garcia MZ et al (2010) Hormonal therapy and sex reassignment: a systematic review and meta-analysis of quality of life and psychosocial outcomes. Clin Endocrinol (Oxf) 72(2):214\u2013231. https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03625.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"1694_CR92","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1210\/jc.2017-01643","volume":"102","author":"S Maraka","year":"2017","unstructured":"Maraka S, Singh Ospina N, Rodriguez-Gutierrez R, Davidge-Pitts CJ, Nippoldt TB, Prokop LJ, Murad MH (2017) Sex steroids and cardiovascular outcomes in transgender individuals: a systematic review and meta-analysis. J Clin Endocrinol Metab 102(11):3914\u20133923. https:\/\/doi.org\/10.1210\/jc.2017-01643","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1694_CR93","doi-asserted-by":"publisher","first-page":"205","DOI":"10.7326\/M17-2785","volume":"169","author":"D Getahun","year":"2018","unstructured":"Getahun D, Nash R, Flanders WD et al (2018) Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study. Ann Intern Med 169(4):205\u2013213. https:\/\/doi.org\/10.7326\/M17-2785","journal-title":"Ann Intern Med"},{"issue":"4","key":"1694_CR94","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.119.005597","volume":"12","author":"T Alzahrani","year":"2019","unstructured":"Alzahrani T, Nguyen T, Ryan A et al (2019) Cardiovascular disease risk factors and myocardial infarction in the transgender population. Circ Cardiovasc Qual Outcomes 12(4):e005597. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.119.005597","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"1694_CR95","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1373\/clinchem.2018.288316","volume":"65","author":"J Khan","year":"2019","unstructured":"Khan J, Schmidt RL, Spittal MJ et al (2019) Venous thrombotic risk in transgender women undergoing estrogen therapy: a systematic review and metaanalysis. Clin Chem 65(1):57\u201366. https:\/\/doi.org\/10.1373\/clinchem.2018.288316","journal-title":"Clin Chem"},{"issue":"7","key":"1694_CR96","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.jsxm.2021.04.006","volume":"18","author":"VS Kotamarti","year":"2021","unstructured":"Kotamarti VS, Nicolas Greige G, Adee JH et al (2021) Risk for venous thromboembolism in transgender patients undergoing cross-sex hormone treatment: a systematic review. J Sex Med 18(7):1280\u20131291. https:\/\/doi.org\/10.1016\/j.jsxm.2021.04.006","journal-title":"J Sex Med"},{"issue":"1","key":"1694_CR97","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.bone.2013.01.039","volume":"54","author":"E Van Caenegem","year":"2013","unstructured":"Van Caenegem E, Taes Y, Wierckx K et al (2013) Low bone mass is prevalent in male-to-female transsexual persons before the start of cross-sex hormonal therapy and gonadectomy. Bone 54(1):92\u201397. https:\/\/doi.org\/10.1016\/j.bone.2013.01.039","journal-title":"Bone"},{"key":"1694_CR98","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1002\/jbmr.3102","volume":"32","author":"CM Wiepjes","year":"2017","unstructured":"Wiepjes CM, Vlot MC, Klaver M et al (2017) Bone mineral density increases in trans persons after 1 year of hormonal treatment: a multicenter prospective observational study. J Bone Miner Res 32:1252\u20131260. https:\/\/doi.org\/10.1002\/jbmr.3102","journal-title":"J Bone Miner Res"},{"key":"1694_CR99","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1210\/jc.2017-01642","volume":"102","author":"N Singh-Ospina","year":"2017","unstructured":"Singh-Ospina N, Maraka S, Rodriguez-Gutierrez R et al (2017) Effect of sex steroids on the bone health of transgender individuals: a systematic review and meta-analysis. J Clin Endocrinol Metab 102:3904\u20133913. https:\/\/doi.org\/10.1210\/jc.2017-01642","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1694_CR100","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12018-019-09261-3","volume":"17","author":"MS Rothman","year":"2019","unstructured":"Rothman MS, Iwamoto SJ (2019) Bone health in the transgender population. Clin Rev Bone Miner Metab 17(2):77\u201385. https:\/\/doi.org\/10.1007\/s12018-019-09261-3","journal-title":"Clin Rev Bone Miner Metab"},{"issue":"7","key":"1694_CR101","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/brain\/awy108","volume":"141","author":"NM Nota","year":"2018","unstructured":"Nota NM, Wiepjes CM, de Blok CJM et al (2018) The occurrence of benign brain tumours in transgender individuals during cross-sex hormone treatment. Brain 141(7):2047\u20132054","journal-title":"Brain"},{"key":"1694_CR102","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/j.1365-2125.2011.04031.x","volume":"72","author":"M Gil","year":"2011","unstructured":"Gil M, Oliva B, Timoner J et al (2011) Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: evidence from a populationbased cohort study. Br J Clin Pharmacol 72:965\u2013968. https:\/\/doi.org\/10.1111\/j.1365-2125.2011.04031.x","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"1694_CR103","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jadohealth.2020.03.003","volume":"67","author":"AM Gomez","year":"2020","unstructured":"Gomez AM, \u00d0\u1ed7 L, Ratliff A et al (2020) Contraceptive beliefs, needs, and care experiences among transgender and nonbinary young adults. J Adolesc Health 67(4):597\u2013602. https:\/\/doi.org\/10.1016\/j.jadohealth.2020.03.003","journal-title":"J Adolesc Health"},{"key":"1694_CR104","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.3390\/jcm9113733","volume":"9","author":"M Mirabella","year":"2020","unstructured":"Mirabella M, Giovanardi G, Fortunato A et al (2020) The Body I live in perceptions and meanings of body dissatisfaction in young transgender adults: a qualitative study. J Clin Med 9:3733. https:\/\/doi.org\/10.3390\/jcm9113733","journal-title":"J Clin Med"},{"key":"1694_CR105","doi-asserted-by":"publisher","first-page":"65S","DOI":"10.1097\/01.AOG.0000533319.47797.7e","volume":"131","author":"L Abern","year":"2018","unstructured":"Abern L, Maguire K (2018) Contraception knowledge in transgender individuals: are we doing enough? Obstet Gynecol 131:65S. https:\/\/doi.org\/10.1097\/01.AOG.0000533319.47797.7e","journal-title":"Obstet Gynecol"},{"key":"1694_CR106","doi-asserted-by":"publisher","first-page":"231e7","DOI":"10.1089\/trgh.2016.0032","volume":"1","author":"LM Porsch","year":"2016","unstructured":"Porsch LM, Dayananda I, Dean G et al (2016) An exploratory study of transgender New Yorkers\u2019 Use of sexual health services and interest in receiving services at planned parenthood of New York city. Transgend Health 1:231e7. https:\/\/doi.org\/10.1089\/trgh.2016.0032","journal-title":"Transgend Health"},{"key":"1694_CR107","doi-asserted-by":"publisher","first-page":"501e13","DOI":"10.1089\/apc.2010.0059","volume":"24","author":"SL Reisner","year":"2010","unstructured":"Reisner SL, Perkovich B, Mimiaga MJ et al (2010) A mixed methods study of the sexual health needs of New England transmen who have sex with nontransgender men. AIDS Patient Care STDS 24:501e13","journal-title":"AIDS Patient Care STDS"},{"key":"1694_CR108","doi-asserted-by":"publisher","first-page":"579e88","DOI":"10.1007\/s10815-018-1395-y","volume":"36","author":"AC Tishelman","year":"2019","unstructured":"Tishelman AC, Sutter ME, Chen D et al (2019) Health care provider perceptions of fertility preservation barriers and challenges with transgender patients and families: qualitative responses to an international survey. J Assist Reprod Genet 36:579e88","journal-title":"J Assist Reprod Genet"},{"key":"1694_CR109","doi-asserted-by":"publisher","first-page":"221e6","DOI":"10.1016\/j.contraception.2017.07.007","volume":"96","author":"AM Gomez","year":"2017","unstructured":"Gomez AM, Wapman M et al (2017) Under (implicit) pressure: young black and latina women\u2019s perceptions of contraceptive care. Contraception 96:221e6. https:\/\/doi.org\/10.1016\/j.contraception.2017.07.007","journal-title":"Contraception"},{"key":"1694_CR110","doi-asserted-by":"publisher","first-page":"1120e7","DOI":"10.1097\/AOG.0000000000000540","volume":"124","author":"AD Light","year":"2014","unstructured":"Light AD, Obedin-Maliver J, Sevelius JM et al (2014) Transgender men who experienced pregnancy after female-to-male gender transitioning. Obstet Gynecol 124:1120e7. https:\/\/doi.org\/10.1097\/AOG.0000000000000540","journal-title":"Obstet Gynecol"},{"key":"1694_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/s41443-021-00412-z","author":"I Mancini","year":"2021","unstructured":"Mancini I, Alvisi S, Gava G et al (2021) Contraception across transgender. Int J Impot Res. https:\/\/doi.org\/10.1038\/s41443-021-00412-z","journal-title":"Int J Impot Res"},{"issue":"4","key":"1694_CR112","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.contraception.2018.06.006","volume":"98","author":"A Light","year":"2018","unstructured":"Light A, Wang LF, Zeymo A, Gomez-Lobo V (2018) Family planning and contraception use in transgender men. Contraception 98(4):266\u2013269. https:\/\/doi.org\/10.1016\/j.contraception.2018.06.006","journal-title":"Contraception"},{"issue":"5","key":"1694_CR113","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.jsxm.2018.03.083","volume":"15","author":"MK Auer","year":"2018","unstructured":"Auer MK, Fuss J, Nieder TO et al (2018) Desire to have children among transgender people in germany: a cross-sectional multi-center study. J Sex Med 15(5):757\u2013767. https:\/\/doi.org\/10.1016\/j.jsxm.2018.03.083","journal-title":"J Sex Med"},{"issue":"9","key":"1694_CR114","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1080\/13691058.2015.1042919","volume":"17","author":"H von Doussa","year":"2015","unstructured":"von Doussa H, Power J, Riggs D et al (2015) Imagining parenthood: the possibilities and experiences of parenthood among transgender people. Cult Health Sex 17(9):1119\u20131131. https:\/\/doi.org\/10.1080\/13691058.2015.1042919","journal-title":"Cult Health Sex"},{"issue":"1","key":"1694_CR115","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/15532739.2019.1692750","volume":"21","author":"J Defreyne","year":"2020","unstructured":"Defreyne J, Van Schuylenbergh J, Motmans J et al (2020) Parental desire and fertility preservation in assigned male at birth transgender people living in Belgium. Int J Transgend Health 21(1):45\u201357. https:\/\/doi.org\/10.1080\/15532739.2019.1692750","journal-title":"Int J Transgend Health"},{"issue":"6","key":"1694_CR116","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/01.med.0000436184.42554.b7","volume":"20","author":"G T\u2019Sjoen","year":"2013","unstructured":"T\u2019Sjoen G, Van Caenegem E, Wierckx K et al (2013) Transgenderism and reproduction. Curr Opin Endocrinol Diabetes Obes 20(6):575\u2013579. https:\/\/doi.org\/10.1097\/01.med.0000436184.42554.b7","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"1694_CR117","volume-title":"WHO laboratory manual for the examination and processing of human semen","author":"WHO","year":"2021","unstructured":"WHO (2021) WHO laboratory manual for the examination and processing of human semen, 6th edn. World Health Organization, Geneva","edition":"6"},{"key":"1694_CR118","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1111\/and.12330","volume":"47","author":"A Hamada","year":"2015","unstructured":"Hamada A, Kingsberg S, Wierckx K et al (2015) (2015) Semen characteristics of transwomen referred for sperm banking before sex transition: a case series. Andrologia 47:832\u2013838","journal-title":"Andrologia"},{"key":"1694_CR119","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/andr.12527","volume":"6","author":"K Li","year":"2018","unstructured":"Li K, Rodriguez D, Gabrielsen JS et al (2018) Sperm cryopreservation of transgender individuals: trends and findings in the past decade. Andrology 6:860\u2013864. https:\/\/doi.org\/10.1111\/andr.12527","journal-title":"Andrology"},{"key":"1694_CR120","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.urology.2018.10.005","volume":"124","author":"AJ Adeleye","year":"2019","unstructured":"Adeleye AJ, Reid G, Kao CN et al (2019) Semen parameters among transgender women with a history of hormonal treatment. Urology 124:136\u2013141. https:\/\/doi.org\/10.1016\/j.urology.2018.10.005","journal-title":"Urology"},{"issue":"4","key":"1694_CR121","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1093\/humrep\/del474","volume":"22","author":"T Baba","year":"2007","unstructured":"Baba T, Endo T, Honnma H et al (2007) Association between polycystic ovary syndrome and female-to-male transsexuality. Hum Reprod 22(4):1011\u20131016. https:\/\/doi.org\/10.1093\/humrep\/del474","journal-title":"Hum Reprod"},{"issue":"1","key":"1694_CR122","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1210\/jcem-69-1-151","volume":"69","author":"T Spinder","year":"1989","unstructured":"Spinder T, Spijkstra JJ, van den Tweel JG et al (1989) The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects. J Clin Endocrinol Meta 69(1):151\u2013157. https:\/\/doi.org\/10.1210\/jcem-69-1-151","journal-title":"J Clin Endocrinol Meta"},{"issue":"2","key":"1694_CR123","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/humrep\/des385","volume":"28","author":"K Ikeda","year":"2013","unstructured":"Ikeda K, Baba T, Noguchi H et al (2013) Excessive androgen exposure in female-to-male transsexual persons of reproductive age induces hyperplasia of the ovarian cortex and stroma but not polycystic ovary morphology. Hum Reprod 28(2):453\u2013461. https:\/\/doi.org\/10.1093\/humrep\/des385","journal-title":"Hum Reprod"},{"issue":"6","key":"1694_CR124","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1097\/AOG.0000000000002036","volume":"129","author":"S Maxwell","year":"2017","unstructured":"Maxwell S, Noyes N, Keefe D et al (2017) Pregnancy outcomes after fertility preservation in transgender men. Obstet Gynecol 129(6):1031\u20131034. https:\/\/doi.org\/10.1097\/AOG.0000000000002036","journal-title":"Obstet Gynecol"},{"key":"1694_CR125","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/humrep\/dew323","volume":"32","author":"G Armuand","year":"2017","unstructured":"Armuand G, Dhejne C, Olofsson JI et al (2017) Transgender men\u2019s experiences of fertility preservation: a qualitative study. Hum Reprod 32:383\u2013390. https:\/\/doi.org\/10.1093\/humrep\/dew323","journal-title":"Hum Reprod"},{"key":"1694_CR126","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s11154-018-9449-0","volume":"19","author":"LJ Gooren","year":"2018","unstructured":"Gooren LJ, T\u2019Sjoen G et al (2018) (2018) Endocrine treatment of aging transgender people. Rev Endocr Metab Disord 19:253\u2013262. https:\/\/doi.org\/10.1007\/s11154-018-9449-0","journal-title":"Rev Endocr Metab Disord"},{"key":"1694_CR127","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.bone.2013.01.039","volume":"54","author":"E Van Caenegem","year":"2013","unstructured":"Van Caenegem E, Taes Y, Wierckx K et al (2013) Low bone mass is prevalent in male-to-female transsexual persons before the start of cross-sex hormonal therapy and gonadectomy. Bone 54:92\u201397. https:\/\/doi.org\/10.1016\/j.bone.2013.01.039","journal-title":"Bone"},{"issue":"1","key":"1694_CR128","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/jbmr.3862","volume":"35","author":"CM Wiepjes","year":"2020","unstructured":"Wiepjes CM, Jm de Blok C, Staphorsius AS et al (2020) Fracture risk in trans women and trans men using long-term gender-affirming hormonal treatment: a nationwide cohort study. J Bone Miner Res 35(1):64\u201370. https:\/\/doi.org\/10.1002\/jbmr.3862","journal-title":"J Bone Miner Res"},{"issue":"6","key":"1694_CR129","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.clbc.2011.06.006","volume":"11","author":"T Shao","year":"2011","unstructured":"Shao T, Grossbard ML, Klein P (2011) Breast cancer in female-tomaletranssexuals: two cases with a review of physiology and management. Clin Breast Cancer 11(6):417\u2013419. https:\/\/doi.org\/10.1016\/j.clbc.2011.06.006","journal-title":"Clin Breast Cancer"},{"issue":"4","key":"1694_CR130","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/s0960-9776(03)00033-x","volume":"12","author":"RJ Burcombe","year":"2003","unstructured":"Burcombe RJ, Makris A, Pittam M et al (2003) Breast cancer after bilateral subcutaneous mastectomy in a female-to-male transsexual. Breast 12(4):290\u2013293. https:\/\/doi.org\/10.1016\/s0960-9776(03)00033-x","journal-title":"Breast"},{"key":"1694_CR131","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004143.pub5","author":"J Marjoribanks","year":"2017","unstructured":"Marjoribanks J, Farquhar C, Roberts H et al (2017) Longterm hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD004143.pub5","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"1694_CR132","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.endonu.2012.07.004","volume":"60","author":"MT Bergoglio","year":"2013","unstructured":"Bergoglio MT, Gomez-Balaguer M, Almonacid Folch E et al (2013) Symptomatic meningioma induced by cross-sex hormone treatment in a male-to-female transsexual. Endocrinol Nutr 60(5):264\u2013267. https:\/\/doi.org\/10.1016\/j.endonu.2012.07.004","journal-title":"Endocrinol Nutr"},{"key":"1694_CR133","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f5298","volume":"347","author":"BH Stegeman","year":"2013","unstructured":"Stegeman BH, de Bastos M, Rosendaal FR et al (2013) Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis. BMJ 347:f5298. https:\/\/doi.org\/10.1136\/bmj.f5298","journal-title":"BMJ"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-021-01694-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-021-01694-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-021-01694-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T15:09:48Z","timestamp":1699715388000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-021-01694-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,22]]},"references-count":133,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["1694"],"URL":"https:\/\/doi.org\/10.1007\/s40618-021-01694-2","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,22]]},"assertion":[{"value":"29 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no competing interests for the present article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}